Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 1998. Atlanta, Ga: US Dept of Health and Human Services; 1999:1-84.
Centers for Disease Control and Prevention, for the Advisory Council
for the Elimination of Tuberculosis (ACET). Tuberculosis elimination revisited: obstacles, opportunities, and a
renewed commitment. MMWR Morb Mortal Wkly Rep.1999;48(RR-9):1-13.
Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless: a prospective study. Am J Respir Crit Care Med.2000;162:460-464.
Centers for Disease Control and Prevention. Prevention and control of tuberculosis among homeless persons: recommendations
of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep.1992;41(RR-5):13-23.
Gelberg L, Panarites CJ, Morgenstern H, Leake B, Andersen RM, Koegel P. Tuberculosis skin testing among homeless adults. J Gen Intern Med.1997;12:25-33.
Zolopa AR, Hahn JA, Gorter R.
et al. HIV and tuberculosis infection in San Francisco's homeless adults:
prevalence and risk factors in a representative sample. JAMA.1994;272:455-461.
Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless
shelters. Int J Tuberc Lung Dis.1999;3:613-619.
Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New
York City shelter: association with Mycobacterium tuberculosis infection. Arch Intern Med.1990;150:2030-2036.
Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men: a description
of its evolution and control. Am Rev Respir Dis.1991;143:257-261.
Curtis AB, Ridzon R, Novick LF.
et al. Analysis of Mycobacterium tuberculosis transmission
patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis.2000;4:308-313.
Small PM, Hopewell PC, Singh SP.
et al. The epidemiology of tuberculosis in San Francisco: a population-based
study of conventional and molecular methods. N Engl J Med.1994;330:1703-1709.
Barnes PF, el-Hajj H, Preston-Martin S.
et al. Transmission of tuberculosis among the urban homeless. JAMA.1996;275:305-307.
Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus,
homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis.1991;144:745-749.
Nazar-Stewart V, Nolan CM. Results of a directly observed intermittent isoniazid preventive therapy
program in a shelter for homeless men. Am Rev Respir Dis.1992;146:57-60.
Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis: epidemiology
and effect on the outcome of treatment. Chest.1997;111:1168-1173.
Bock NN, McGowan Jr JE, Blumberg HM. Few opportunities found for tuberculosis prevention among the urban
poor. Int J Tuberc Lung Dis.1998;2:124-129.
Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med.1995;333:222-227.
Barrow SM, Herman DB, Cordova P, Struening EL. Mortality among homeless shelter residents in New York City. Am J Public Health.1999;89:529-534.
Hibbs JR, Benner L, Klugman L.
et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med.1994;331:304-309.
Phelan JC, Link BG. Who are "the homeless"? reconsidering the stability and composition
of the homeless population. Am J Public Health.1999;89:1334-1338.
Brewer TF, Heymann SJ, Colditz GA.
et al. Evaluation of tuberculosis control policies using computer simulation. JAMA.1996;276:1898-1903.
Link BG, Phelan JC, Bresnahan M, Moore R, Susser E. Lifetime and five-year prevalence of homelessness in the United States:
new evidence on an old debate. Am J Orthopsychiatry.1995;65:347-354.
Burt MR, Aron LY, Douglas T.
et al. Homelessness: Programs and the People They Serve. Findings of the National Survey of Homeless Assistance Providers
and Clients: Interagency Council on the Homeless. Washington, DC: Urban Institute;
St Lawrence J, Brasfield TL. HIV risk behavior among homeless adults. AIDS Educ Prev.1995;7:22-31.
Polesky A, Farber HW, Gottlieb DJ.
et al. Rifampin preventative therapy for tuberculosis in Boston's homeless. Am J Respir Crit Care Med.1996;154:1473-1477.
Shlay JC, Blackburn D, O'Keefe K, Raevsky C, Evans M, Cohn DL. HIV seroprevalence and risk assessment in a homeless population in
Denver. Sex Transm Dis.1996;23:304-311.
Etkind S, Boutotte J, Ford J, Singletore L, Nardell EA. Treating hard to treat patients in Massachusetts. Semin Respir Infect.1991;6:273-282.
Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance
case definitions for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep.1992;41(suppl RR-17):1-13.
Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in
adolescence and early adult life. BMJ.1977;2:293-295.
Daley CL, Small PM, Schecter GF.
et al. An outbreak of tuberculosis with accelerated progression among persons
infected with the human immunodeficiency virus: an analysis using restriction-fragment-length
polymorphisms. N Engl J Med.1992;326:231-235.
Comstock GW, Woolpert SF, Livesay VT. Tuberculosis studies in Muscogee County, Georgia: twenty-year evalulation
of a community trial of BCG vaccination. Public Health Rep.1976;91:276-280.
Markowitz N, Hansen NI, Hopewell PC.
et al. for the Pulmonary Complications of HIV Infection Study Group. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med.1997;126:123-132.
Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous
Centers for Disease Control and Prevention. Table 10: tuberculosis cases resistant to isoniazid and/or rifampin:
59 reporting areas, 1995. In: Reported Tuberculosis in the United States,
1995. Atlanta, Ga: US Dept of Health and Human Services; 1996:26.
Gordin FM, Nelson ET, Matts JP.
et al. The impact of human immunodeficiency virus infection on drug-resistant
tuberculosis. Am J Respir Crit Care Med.1996;154:1478-1483.
Hobby GL, Johnson PM, Boytar-Papirnyk V. Primary drug resistance: a continuing study of drug resistance in tuberculosis
in a veteran population within the United States, X: September 1970 to September
1973. Am Rev Respir Dis.1974;110:95-98.
Turrett GS, Telzak EE, Torian LV.
et al. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis.1995;21:1238-1244.
Telzak EE, Sepkowitz K, Alpert P.
et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med.1995;333:907-911.
Goble M, Iseman MD, Madsen LA.
et al. Treatment of 171 patients with pulmonary tuberculosis resistant to
isoniazid and rifampin. N Engl J Med.1993;328:527-532.
Park MM, Davis AL, Schluger NW.
et al. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate
therapy. Am J Respir Crit Care Med.1996;153:317-324.
Salomon N, Perlman DC, Friedmann P.
et al. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis.1995;21:1245-1252.
Small PM, Schecter GF, Goodman PC, Sande MA, Chassion RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency
virus infection. N Engl J Med.1991;324:289-294.
Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62-dose, 6-month therapy for pulmonary and extra-pulmonary tuberculosis. Ann Intern Med.1990;112:407-415.
China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese
patients with smear-positive tuberculosis. Lancet.1996;347:358-362.
Combs DL, O'Brien RJ, Geiter LJ. US Public Health Service tuberculosis short-course chemotherapy trial
21: effectiveness, toxicity, and acceptability. Ann Intern Med.1990;112:397-406.
Rose DN, Schecter GB, Sacks HS. Preventive medicine for HIV-infected patients: an analysis of isoniazid
prophylaxis for tuberculin reactors and for anergic patients. J Gen Intern Med.1992;7:589-594.
Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a US Public Health Service cooperative
surveillance study. Am Rev Respir Dis.1978;117:991-1001.
Colditz GA, Brewer TF, Berkey CS.
et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis
of the published literature. JAMA.1994;271:698-702.
Seaholm SK, Ackerman E, Wu SC. Latin hypercube sampling and the sensitivity analysis of a Monte Carlo
epidemic model. Int J Biomed Comput.1988;23:97-112.
Blower SM, McLean AR, Porco TC.
et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med.1995;1:815-821.
Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission:
an HIV model, as an example. Int Stat Rev.1994;62:229-243.
Gallagher TC, Andersen RM, Koegel P, Gelberg L. Determinants of regular source of care among homeless adults in Los
Angeles. Med Care.1997;35:814-830.
Rendleman NJ. Mandated tuberculosis screening in a community of homeless persons. Am J Prev Med.1999;17:108-113.
Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep.2000;49(RR-6):1-51.
Comstock GW. How much isoniazid is needed for prevention and control of tuberculosis
among immunocompetent adults? Int J Tuberc Lung Dis.1999;3:847-850.
Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis
in the United States. MMWR Morb Mortal Wkly Rep.1996;45(RR-4):1-18.
Counts GW, Gregory DF, Spearman JG.
et al. Group A meningococcal disease in the US Pacific Northwest: epidemiology,
clinical features, and effect of a vaccination control program. Rev Infect Dis.1984;6:640-648.
LeBaron CW, Starnes D, Dini EF, Chambliss JW, Chaney M. The impact of interventions by a community-based organization on inner-city
vaccination coverage. Arch Pediatr Adolesc Med.1998;152:327-332.
Gelberg L, Andersen RM, Leake B. The behavioral model for vulnerable populations: application to medical
care use and outcomes for homeless people. Health Serv Res.2000;34:1273-1302.
Gelberg L, Doblin BH, Leake B. Ambulatory health services provided to low-income and homeless adult
patients in a major community health center. J Gen Intern Med.1996;11:156-162.
Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless: a trial to improve adherence
to referral. Arch Intern Med.1996;156:161-165.
Tulsky JP, Pilote L, Hahn JA.
et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled
trial. Arch Intern Med.2000;160:697-702.
Pablo-Mendez A, Knirsch CA, Barr GR, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences
in New York City. Am J Med.1997;102:164-170.
Salomon N, Perlman DC, Rubenstein A, Mandelman D, McKinley FW, Yancovitz SR. Implementation of universal directly observed therapy at a New York
City hospital and evaluation of an out-patient directly observed therapy program. Int J Tuberc Lung Dis.1997;1:397-404.
El-Sadr W, Medard F, Barthaud V. Directly observed therapy for tuberculosis: the Harlem hospital experience,
1993. Am J Public Health.1996;86:1146-1149.
LoBue PA, Cass R, Lobo D, Moser K, Catanzaro A. Development of housing programs to aid in the treatment of tuberculosis
in homeless individuals: a pilot study. Chest.1999;115:218-223.
Diez E, Claveria J, Serra T.
et al. Evaluation of a social health intervention among homeless tuberculosis
patients. Tuber Lung Dis.1996;77:420-424.
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City—turning the tide. N Engl J Med.1995;333:229-233.
Geiter LJ.for the Institute of Medicine. Ending Neglect: The Elimination of Tuberculosis in
the United States. Washington, DC: National Academy of Sciences; 2000.